PhaseOM Unifies Phase-Separation Analysis and Key-Residue Detection in One Framework

Liquid–liquid phase separation, the process by which molecules spontaneously condense into concentrated droplets without a surrounding membrane, has become one of biology’s most closely watched phenomena. A new computational framework called PhaseOM promises to make the process easier to dissect by determining not only whether a protein is likely to participate in phase separation, but also what role it plays, which regions of its sequence are disordered, and which individual residues may help drive the formation of biomolecular condensates. The framework, described by researchers from multiple institutions in a study published online in the Journal of Advanced Research, could give scientists a faster way to identify the molecular “switches” controlling membrane-free compartments inside cells. Such compartments include nucleoli, P bodies and other condensates that organize biochemical reactions without the walls of a traditional organelle.

The biological principle behind the work is deceptively simple. In a liquid–liquid phase separation event, proteins, RNA and other molecules separate from the surrounding cellular fluid much as oil separates from water, creating a dense phase enriched in selected components and a dilute phase containing the remainder. Unlike a crystal or a permanently aggregated protein, a liquid condensate can remain dynamic: molecules enter and leave, droplets fuse, and interactions can be rapidly remodeled. These properties allow cells to concentrate enzymes, RNA-processing factors and DNA-repair proteins precisely where they are needed. The molecular forces involved are generally weak when considered individually, but they become powerful when repeated across many interaction sites. Electrostatic attraction, cation–π and π–π interactions, transient binding motifs and flexible protein segments can collectively create the multivalent network needed for condensation.

A central feature of many phase-separating proteins is the intrinsically disordered region, or IDR. Unlike a folded domain, which adopts a relatively stable three-dimensional structure, an IDR samples a constantly shifting ensemble of conformations. Its flexibility and composition can make it especially effective at forming numerous temporary contacts with other proteins or nucleic acids. IDRs are often enriched in charged, polar or interaction-prone residues, although no single sequence pattern explains every condensate. This diversity has made prediction difficult. Earlier computational tools typically searched for narrow signatures, such as prion-like amino-acid composition, aromatic interaction potential or the presence of arginine and tyrosine. More recent systems have incorporated evolutionary conservation, structural predictions, protein–protein interactions, imaging data and machine-learning embeddings, but many still treat all phase-separating proteins as if they perform the same job.

PhaseOM was designed to address that missing distinction. Its first task is to classify a candidate protein as either a scaffold or a client. Scaffolds are the core components that initiate, organize or maintain a condensate. They provide much of the interaction network that gives the assembly its physical integrity. Clients, by contrast, are recruited into an existing condensate and become selectively concentrated there, but generally do not serve as the principal drivers of its formation. The difference matters because two proteins can both be found inside the same droplet while contributing to it in fundamentally different ways. Misclassifying a client as a scaffold could lead researchers toward the wrong experiments, obscure the mechanism of condensation and complicate efforts to target disease-associated condensates.

The framework combines several machine-learning strategies in a sequential workflow. For scaffold detection, PhaseOM uses embeddings generated by ProtT5-XL-U50, a protein-language model that represents sequence information numerically, together with a graph-attention network. The graph incorporates predicted spatial relationships between amino acids, connecting residues whose alpha-carbon atoms lie within 10 angstroms of one another. This allows the model to combine sequence-derived information with a representation of local three-dimensional proximity. The scaffold classifier achieved an area under the receiver operating characteristic curve, or AUC, of 0.9954. An AUC of 1.0 indicates perfect separation between classes, although performance measured on curated data does not guarantee identical accuracy on proteins outside the training distribution.

Client proteins are evaluated with a separate ensemble classifier built from 22 optimized physicochemical and structural features. These features are intended to capture properties such as composition, charge, flexibility and predicted structural behavior that may distinguish recruited proteins from condensate-driving scaffolds. The client model reached an AUC of 0.9474. The system applies a probability threshold of 0.5 to both categories; if a protein exceeds that threshold for both scaffold and client, the class with the higher probability is selected. This arrangement reflects the biological reality that classification is not always clean. Some proteins may participate in more than one condensate, switch roles depending on cellular context or act as a scaffold in one environment and a client in another.

After assigning a functional category, PhaseOM searches for IDR-associated phase-separation regions. Its disorder model uses 17 features and achieved an AUC of 0.9835. The researchers then apply a fourth model to locate key residues within those regions. This residue-level predictor is a multilayer perceptron equipped with multi-head self-attention and processes 1,058-dimensional input data. Attention mechanisms allow a model to weigh relationships among different positions in a sequence rather than treating every residue as an isolated feature. The key-residue model produced an AUC of 0.8092, lower than the framework’s protein- and region-level tasks but potentially useful for prioritizing residues for laboratory testing. In practice, the output could direct mutagenesis experiments toward a small number of candidate positions rather than requiring researchers to alter an entire disordered region.

The predictions also exposed biochemical differences between the two functional classes. Client proteins tended to adopt more expanded conformations and contained higher frequencies of cysteine and histidine, residues that may contribute to π-related or electrostatic interactions in particular molecular settings. Their IDRs were associated with an excess of negative charge and increased flexibility. Scaffold proteins, in contrast, showed greater representation of tyrosine and arginine and more complex interaction patterns. These observations do not imply that a single amino acid determines a protein’s role. Phase separation depends on the combined behavior of many residues, the presence of RNA or other binding partners, post-translational modifications, concentration, temperature, salt conditions and the cellular environment. Instead, the patterns provide statistical clues that can be integrated into a broader mechanistic model.

The study reports that PhaseOM outperformed Seq2Phase on independent tests, improving client-protein AUC by 0.21 and scaffold-protein AUC by more than 0.07. The authors attribute much of the gain to the framework’s integrated structural and ensemble-based architecture, which connects functional classification to disorder mapping and residue identification. They also tested the system on alpha-synuclein isoforms, proteins of particular interest because abnormal assemblies of alpha-synuclein are linked to neurodegenerative disease. Residue-level validation showed 76 to 91 percent accuracy for IDR assignments, with stronger agreement in longer disordered regions. Predicted scaffold probabilities exceeded 0.91 across the isoforms, consistent with the biological consensus used in the analysis. These results suggest that the system can reproduce known features, although experimental validation across a wider range of proteins will be essential.

The potential applications extend beyond cataloguing proteins. Aberrant condensates have been associated with cancer, neurodegeneration and failures in RNA processing, and their formation may sometimes precede irreversible aggregation. A tool that identifies the residues and regions most responsible for condensation could help researchers test whether a disease-linked mutation changes a protein’s scaffold activity, client recruitment or interaction landscape. It might also support the design of molecules that selectively disrupt pathological condensates while preserving normal ones. PhaseOM is not itself a treatment and cannot establish causation from sequence alone. Its predictions require biochemical and cellular experiments, particularly because phase behavior is strongly context-dependent. Even so, by organizing the analysis into a hierarchy—from scaffold or client, to disordered region, to critical residue—the framework offers a practical route from a raw protein sequence to testable molecular hypotheses. The researchers have made the model architecture and feature configurations available through a public GitHub repository, potentially allowing other groups to evaluate and extend the approach as the rapidly expanding field of biomolecular condensates moves toward more precise, residue-level biology.